We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XM
3551
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-41,013
Closed -$1.57M
HCNEU
3552
DELISTED
Jaws Hurricane Acquisition Corp. Unit
HCNEU
-200,000
Closed -$2.01M
LITTU
3553
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
-250,000
Closed -$2.49M
ZTAQU
3554
DELISTED
Zimmer Energy Transition Acquisition Corp. Units
ZTAQU
-451,262
Closed -$4.53M
CYXT
3555
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
-999,966
Closed -$10M
RONI.U
3556
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
-250,000
Closed -$2.56M
STSA
3557
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-70,247
Closed -$495K
PSPC.U
3558
DELISTED
Post Holdings Partnering Corporation Units, each consisting of one share of Series A common stock, and one-third of one redeemable warrant
PSPC.U
-200,000
Closed -$2.08M
APTX
3559
DELISTED
Aptinyx Inc. Common Stock
APTX
-19,776
Closed -$56K
VLATU
3560
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
-150,000
Closed -$1.49M
MAXR
3561
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-12,667
Closed -$508K
OSH
3562
DELISTED
Oak Street Health, Inc.
OSH
-40,138
Closed -$2.35M
ORIAU
3563
DELISTED
Orion Biotech Opportunities Corp. Units
ORIAU
-275,000
Closed -$2.78M
ARVL
3564
DELISTED
Arrival Ordinary Shares
ARVL
-12,273
Closed -$9.62M
SGFY
3565
DELISTED
Signify Health, Inc.
SGFY
-10,334
Closed -$314K
ATCO
3566
DELISTED
Atlas Corp.
ATCO
-49,667
Closed -$708K
OBSV
3567
DELISTED
ObsEva SA Ordinary Shares
OBSV
-29,778
Closed -$90K
MYOV
3568
DELISTED
Myovant Sciences Ltd.
MYOV
-25,814
Closed -$588K
OIIM
3569
DELISTED
02Micro International
OIIM
-23,834
Closed -$172K
LHCG
3570
DELISTED
LHC Group LLC
LHCG
-15,159
Closed -$3.04M
LCI
3571
DELISTED
Lannett Company, Inc.
LCI
-7,577
Closed -$142K
CPARU
3572
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
-600,000
Closed -$6.02M
GENI.WS
3573
CALL
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
-139,634
Closed -$2.62M
MMX
3574
DELISTED
Maverix Metals Inc. Common Shares
MMX
-82,007
Closed -$442K
EAR
3575
DELISTED
Eargo, Inc. Common Stock
EAR
-374
Closed -$298K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.